Leslie Obert

1.7k total citations
29 papers, 770 citations indexed

About

Leslie Obert is a scholar working on Virology, Epidemiology and Genetics. According to data from OpenAlex, Leslie Obert has authored 29 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Virology, 6 papers in Epidemiology and 6 papers in Genetics. Recurrent topics in Leslie Obert's work include HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers) and Herpesvirus Infections and Treatments (5 papers). Leslie Obert is often cited by papers focused on HIV Research and Treatment (6 papers), Virus-based gene therapy research (5 papers) and Herpesvirus Infections and Treatments (5 papers). Leslie Obert collaborates with scholars based in United States, Canada and United Kingdom. Leslie Obert's co-authors include Edward A. Hoover, Kendall S. Frazier, Lauri Diehl, Mary Jo Burkhard, Petra Koza‐Taylor, Michael Lawton, Candace K. Mathiason, Zaher A. Radi, Seth Sadis and R. R. Bell and has published in prestigious journals such as PLoS ONE, Journal of Virology and Clinical Cancer Research.

In The Last Decade

Leslie Obert

28 papers receiving 742 citations

Peers

Leslie Obert
Vito G. Sasseville United States
Winnie Chan United States
Shirish Paranjpe United States
Susanne Marschner United States
Vito G. Sasseville United States
Leslie Obert
Citations per year, relative to Leslie Obert Leslie Obert (= 1×) peers Vito G. Sasseville

Countries citing papers authored by Leslie Obert

Since Specialization
Citations

This map shows the geographic impact of Leslie Obert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Obert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Obert more than expected).

Fields of papers citing papers by Leslie Obert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Obert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Obert. The network helps show where Leslie Obert may publish in the future.

Co-authorship network of co-authors of Leslie Obert

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Obert. A scholar is included among the top collaborators of Leslie Obert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Obert. Leslie Obert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarzi, Ruth M., Jennifer A. McKenzie, J Oyee, et al.. (2025). Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equations. American Journal of Kidney Diseases. 86(6). 843–853.
2.
Obert, Leslie, Susan A. Elmore, Daniela Ennulat, & Kendall S. Frazier. (2021). A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies. Toxicologic Pathology. 49(5). 996–1023. 41 indexed citations
3.
Frazier, Kendall S., Anne Ryan, Richard A. Peterson, & Leslie Obert. (2019). Kidney Pathology and Investigative Nephrotoxicology Strategies Across Species. Seminars in Nephrology. 39(2). 190–201. 8 indexed citations
4.
Cook, Jon C., Leslie Obert, Petra Koza‐Taylor, et al.. (2017). From the Cover: Fenretinide, Troglitazone, and Elmiron Add to Weight of Evidence Support for Hemangiosarcoma Mode-of-Action From Studies in Mice. Toxicological Sciences. 161(1). 58–75. 4 indexed citations
5.
Coskran, Timothy, Zhijie Jiang, James E. Klaunig, et al.. (2017). Induction of endogenous retroelements as a potential mechanism for mouse-specific drug-induced carcinogenicity. PLoS ONE. 12(5). e0176768–e0176768. 2 indexed citations
6.
Guffroy, Magali, Hadi Falahatpisheh, John M. Kreeger, et al.. (2016). Liver Microvascular Injury and Thrombocytopenia of Antibody–Calicheamicin Conjugates in Cynomolgus Monkeys—Mechanism and Monitoring. Clinical Cancer Research. 23(7). 1760–1770. 47 indexed citations
7.
Criswell, Kay A., Jon C. Cook, D.C. Morse, et al.. (2012). Pregabalin Induces Hepatic Hypoxia and Increases EndothelialCell Proliferation in Mice, a Process Inhibited by DietaryVitamin E Supplementation. Toxicological Sciences. 128(1). 42–56. 15 indexed citations
8.
Radi, Zaher A., Petra Koza‐Taylor, R. R. Bell, et al.. (2011). Increased Serum Enzyme Levels Associated with Kupffer Cell Reduction with No Signs of Hepatic or Skeletal Muscle Injury. American Journal Of Pathology. 179(1). 240–247. 100 indexed citations
9.
Enright, Brian, et al.. (2010). Effects of the histamine H1 antagonist chlorcyclizine on rat fetal palate development. Birth Defects Research Part B Developmental and Reproductive Toxicology. 89(6). 474–484. 2 indexed citations
10.
Laifenfeld, Daphna, Annalyn Gilchrist, David A. Drubin, et al.. (2009). The Role of Hypoxia in 2-Butoxyethanol–Induced Hemangiosarcoma. Toxicological Sciences. 113(1). 254–266. 32 indexed citations
11.
Zaher, Hani, Henriette E. Meyer zu Schwabedissen, Rommel G. Tirona, et al.. (2008). Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin. Molecular Pharmacology. 74(2). 320–329. 88 indexed citations
12.
Marusak, Rosemary A., Zaher A. Radi, & Leslie Obert. (2007). Expression of Ki-67 in the uterus during various stages of the estrous cycle in rats. Experimental and Toxicologic Pathology. 59(3-4). 151–155. 7 indexed citations
13.
Wijsman, John A., et al.. (2007). A practical method to determine the amount of tissue to analyze using laser scanning cytometry. Cytometry Part A. 71A(7). 501–508. 8 indexed citations
15.
Obert, Leslie, et al.. (2006). Detection of cytokine protein expression in mouse lung homogenates using suspension bead array.. Journal of Inflammation. 3(1). 15–15. 14 indexed citations
16.
Davis, John W., Federico Goodsaid, Christopher M. Bral, et al.. (2004). Quantitative gene expression analysis in a nonhuman primate model of antibiotic-induced nephrotoxicity. Toxicology and Applied Pharmacology. 200(1). 16–26. 44 indexed citations
17.
Obert, Leslie & Edward A. Hoover. (2000). Feline Immunodeficiency Virus Clade C Mucosal Transmission and Disease Courses. AIDS Research and Human Retroviruses. 16(7). 677–688. 35 indexed citations
18.
Burkhard, Mary Jo, et al.. (1997). Mucosal Transmission of Cell-Associated and Cell-Free Feline Immunodeficiency Virus. AIDS Research and Human Retroviruses. 13(4). 347–355. 51 indexed citations
19.
Burkhard, Mary Jo, et al.. (1997). Regression of Feline Immunodeficiency Virus Infection. AIDS Research and Human Retroviruses. 13(8). 713–718. 11 indexed citations
20.
Walton, Raquel M., Diane E. Brown, Mary Jo Burkhard, et al.. (1997). Malignant Histiocytosis in a Domestic Cat: Cytomorphologic and Immunohistochemical Features. Veterinary Clinical Pathology. 26(2). 56–60. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026